Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis

Genes Chromosomes and Cancer

Volumn 48, Issue 6, 2009, Pages 468-479

  Moskovszky, Linda ^a   Szuhai, Károly ^b   Krenács, Tibor ^a   Hogendoorn, Pancras C W ^b   Szendroi, Miklós ^a   Benassi, Maria Serena ^c   Kopper, László ^a   Füle, Tibor ^a   Sápi, Zoltán ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CD68 ANTIGEN; PROTEIN BCL 2; PROTEIN CTNNB1; PROTEIN P53; UNCLASSIFIED DRUG; CD68 ANTIGEN, HUMAN; CTNNB1 PROTEIN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; TUMOR PROTEIN;

ADOLESCENT; ADULT; AGED; ANEUPLOIDY; ARTICLE; CHROMOSOMAL INSTABILITY; CHROMOSOME 11P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; MALE; OSTEOCLASTOMA; PLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TETRAPLOIDY; BONE TUMOR; CENTROMERE; CHI SQUARE DISTRIBUTION; CHROMOSOME 11; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; TELOMERE;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BETA CATENIN; BONE NEOPLASMS; CENTROMERE; CHI-SQUARE DISTRIBUTION; CHROMOSOMES, HUMAN, PAIR 11; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENOMIC INSTABILITY; GIANT CELL TUMOR OF BONE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLOIDIES; PROTO-ONCOGENE PROTEINS C-BCL-2; TELOMERE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 65349104745     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20656     Document Type: Article

References (46)

1. Antal I, Sápi Z, Szendroi M. 1999. The prognostic significance of DNA cytophotometry and proliferation index (Ki-67) in giant cell tumors of bone. Int Orthop 23:315-319. (Pubitemid 30103274)
2. Antal I, Sápi Z, Szendroi M. 2000. Malignant transformation of giant cell tumor in the distal radius. Value of the DNA cytophotometry. Orthopade 29:677-683.
3. Bridge JA, Neff JR, Mouron BJ. 1992. Giant cell tumor of bone. Chromosomal analysis of 48 specimens and review of the literature. Cancer Genet Cytogenet 58:2-13.
4. Campanacci M, Baldini N, Boriani S, Sudanese A. 1987. Giant-cell tumor of bone. J Bone Joint Surg Am 69:106-114. (Pubitemid 17030377)
5. Carey FA. 1994. Measurement of nuclear DNA content in histological and cytological specimens: Principles and applications. J Pathol 172:307-312. (Pubitemid 24168646)
6. Castagné C, Mühlematter D, Beyer V, Parlier V, van Melle G, Jotterand M. 2003. Determination of cutoff values to detect small aneuploid clones by interphase fluorescence in situ hybridization: The Poisson model is a more appropriate approach. Should single-cell trisomy 8 be considered a clonal defect? Cancer Genet Cytogenet 147:99-109.
7. Dominkus M, Ruggieri P, Bertoni F, Briccoli A, Picci P, Rocca M, Mercuri M. 2006. Histologically verified lung metastases in benign giant cell tumours - 14 Cases from a single institution. Int Orthop 30:499-504. (Pubitemid 44900558)
8. Enneking WF. 1983.Musculoskeletal Tumor Surgery.New York: Churchill Livingstone.
9. Forsyth RG, Boeck G, Bekaert S, De Meyer T, Taminiau AH, Uyttendaele D, Roels H, Praet MM, Hogendoorn PCW. 2008. Telomere biology in giant cell tumour of bone. J Pathol 214:555-563.
10. Forsyth RG, De Boeck G, Baelde JJ, Taminiau AH, Uyttendaele D, Roels HR, Praet MM, Hogendoorn PCW. 2009. CD33(+) CD14(-) Phenotype is characteristic of multinuclear osteoclast-like cells in giant cell tumor of bone. J Bone Miner Res 24:70-77.
11. Gamberi G, Benassi MS, Böhling T, Ragazzini P, Molendini L, Sollazo MR, Merli M, Ferrari C, Magagnoli G, Bertoni F, Picci P. 1998. Prognostic relevance of c-myc gene expression in giant-cell tumor of bone. J Orthop Res 16:1-7. (Pubitemid 28208220)
12. Gamberi G, Benassi MS, Ragazzini P, Pazzaglia L, Ponticelli F, Ferrari C, Balladelli A, Mercuri M, Gigli M, Bertoni F, Picci P. 2004. Proteases and interleukin-6 gene analysis in 92 giant cell tumors of bone. Ann Oncol 15:498-503. (Pubitemid 38444557)
13. Hruska A, Bollmann R, Kovács RB, Bollmann M, Bodó M, Sápi Z. 2004. DNA ploidy and chromosome (FISH) pattern analysis of peripheral nerve sheath tumors. Cell Oncol 26:335-345. (Pubitemid 40916734)
14. Inazawa J, Inoue J, Imoto I. 2004. Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Rev Cancer Sci 95:559-563. (Pubitemid 39089635)
15. Joyner CJ, Quinn JM, Triffitt JT, Owen ME, Athanasou NA. 1992. Phenotypic characterisation of mononuclear and multinucleated cells of giant cell tumour of bone. Bone Miner 16:37-48.
16. Kandel R, Li SQ, Bell R, Wunder J, Ferguson P, Kauzman A, Diehl JA, Werier J. 2006. Cyclin D1 and p21 is elevated in the giant cells of giant cell tumors. J Orthop Res 24:428-437. (Pubitemid 43773005)
17. Kauzman A, Li SQ, Bradley G, Bell RS, Wunder JS, Kandel R. 2003. Cyclin alterations in giant cell tumor of bone. Mod Pathol 16:210-218. (Pubitemid 36337426)
18. Kawaguchi K, Oda Y, Saito T, Yamamoto H, Takahira T, Tamiya S, Iwamoto Y, Tsuneyoshi M. 2004. Decreased expression of transforming growth factor-β II receptor is associated with that of p27KIP1 in giant cell tumor of bone: A possible link between transforming growth factor-β and cell cycle-related protein. Hum Pathol 35:61-68. (Pubitemid 38133924)
19. Knijnenburg J, Szuhai K, Giltay J, Molenaar L, Sloos W, Poot M, Tanke HJ, Rosenberg C. 2005. Insights from genomic microarrays into structural chromosome rearrangements. Am J Med Genet 132:36-40. (Pubitemid 40070558)
20. Knijnenburg J, van der Burg M, Tanke HJ, Szuhai K. 2007. Optimized amplification and fluorescent labeling of small cell samples for genomic array-CGH. Cytometry 71:585-591. (Pubitemid 47221720)
21. Knowles H, Athanasou N. 2008. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF. J Pathol 215:56-66. (Pubitemid 351619876)
22. Kumta SM, Huang L, Cheng YY, Chow LT, Lee KM, Zheng MH. 2003. Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions. Life Sci 73:1427-1436. (Pubitemid 36794584)
23. Labs K, Perka C, Schmidt GR. 2001. Treatment of stages 2 and 3 giant-cell tumor. Arch Orthop Trauma Surg 121:83-86. (Pubitemid 32124004)
24. Ladanyi M, Tragano F, Huvos A. 1989. Benign metastasizing giant cell tumours of bone. Cancer 64:1521-1526.
25. Lausten GS, Jensen PK, Schiodt T, Lund B. 1996. Local recurrences in giant cell tumour of bone: Long-term follow up of 31 cases. Int Orthop 20:172-176. (Pubitemid 26237604)
26. Mankin HJ, Connor JF, Schiller AL, Perlmutter N, Alho A, McGuire M. 1985. Grading of bone tumors by analysis of nuclear DNA content using flow cytometry. J Bone Joint Surg Am 67:404-413. (Pubitemid 15102108)
27. Masui F, Ushigome S, Fujii K. 1998a. Giant cell tumor of bone: A clinicopathologic study of prognostic factors. Pathol Int 48:723-729. (Pubitemid 28445193)
28. Masui F, Ushigome S, Fuji K. 1998b. Giant cell tumor of bone: An immunohistochemical comparative study. Pathol Int 48:355-361. (Pubitemid 28355159)
29. Molenaar WM, van den Berg E, Veth RP, Dijkhuizen T, de Vries EG. 1994. Tumor progression in a giant cell type malignant fibrous histiocytoma of bone: Clinical, radiologic, histologic, and cytogenetic evidence. Genes Chromosomes Cancer 10:66-70. (Pubitemid 24137271)
30. Monaghan H, Bubb VJ, Sirimujalin R, Millward-Sadler SJ, Salter DM. 2001. Adenomatous polyposis coli (APC), b-catenin, and cadherin are expressed in human bone and cartilage. Histopathology 39:611-619. (Pubitemid 34017135)
31. Murata H, Kusuzaki K, Takeshita H, Hirata M, Hashiguchi S, Ashihara T, Hirasawa Y. 1999. Cytofluorometric DNA ploidy analysis in giant cell tumor of bone: Histologic and prognostic value. Cancer Lett 136:223-229. (Pubitemid 29164396)
32. Nascimento AG, Huvos AG, Marcove RC. 1979. Primary malignant giant cell tumor of bone: A study of eight cases and review of the literature. Cancer 44:1393-1402. (Pubitemid 10197413)
33. Qian J, Bostwick DG, Takahashi S, Borell TJ, Brown JA, Lieber MM, Jenkins RB. 1996. Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens. Am J Pathol 149:1193-1199. (Pubitemid 26337238)
34. Reid R, Banerjee SS, Sciot R. 2002. Giant cell tumour. In: Fletcher CD, Unni KK, Mertens F, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, pp. 310-312.
35. Saeter G, Lee CZ, Schwarze PE, Ous S, Chen DS, Sung JL, Seglen PO. 1988. Changes in ploidy distributions in human liver carcinogenesis. J Natl Cancer Inst 80:1480-1485. (Pubitemid 18264892)
36. Sakkers RJB, Van der Heul RO, Kroon HM, Taminiau AHM, Hogendoorn PCW. 1997. Late malignant transformation of a benign giant-cell tumor of bone. A case report. J Bone Joint Surg Am 79:259-262. (Pubitemid 27108054)
37. Sanerkin NG. 1980. Malignancy, aggressiveness and recurrence in giant cell tumor of bone. Cancer 46:1641-1649. (Pubitemid 10003940)
38. Sara AS, Ayala AG, el Naggar A, Ro JY, Raymond AK, Murray JA. 1990. Giant cell tumor of bone a clinicopathologic and DNA flow cytometric analysis. Cancer 66:2186-2190.
39. Sawyer JR, Goosen LS, Binz RL, Swanson CM, Nicholas RW. 2005. Evidence for telomeric fusions as a mechanism for recurring structural aberrations of chromosome 11 in giant cell tumor of bone. Cancer Genet Cytogenet 159:32-36. (Pubitemid 40614720)
40. Schwartz HS, Eskew JD, Butler MG. 2002. Clonality studies in giant cell tumor of bone. J Orthop Res 20:387-390. (Pubitemid 34218288)
41. Sciot R, Dorfman H, Brys P, Dal Cin P, De Wever I, Fletcher CD, Jonson K, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Samson I, Tallini G, Van den Berghe H, Vanni R, Willen H. 2000. Cytogenetic-morphologic correlations in aneurysmal bone cyst, giant cell tumor of bone and combined lesions. A report from the CHAMP study group. Mod Pathol 13:1206-1210.
42. Siebenrock KA, Unni KK, Rock MG. 1998. Giant-cell tumour of bone metastasising to the lungs. A long-term follow-up. J Bone Joint Surg 80:43-47. (Pubitemid 128472567)
43. Szendroi M. 2004. Giant-cell tumour of bone. J Bone Joint Surg 86:5-12. (Pubitemid 38128697)
44. Szendroi M, Kiss J, Antal I. 2003. Surgical treatment and prognostic factors in giant-cell tumor of bone. Acta Chir Orthop Traumatol Cech 70:142-150. (Pubitemid 36874568)
45. Varanasi SS, Athanasou NA, Briceno I, Papiha SS, Datta HK. 1999. Association of HLA-DRB1 alleles with giant cell tumour of bone. J Clin Pathol 52:782-784. (Pubitemid 29481344)
46. Yang Y, Fruehauf J, Xiang S, Li CJ. 2006. Genomic instability in precancerous lesions before inactivation of tumor suppressors TP53 and APC in patients. Cell Cycle 5:1443-1447. (Pubitemid 44153655)